[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Milestone Pharmaceuticals Inc (MIST)

Milestone Pharmaceuticals Inc (MIST)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Milestone Pharmaceuticals Inc 1111 DR. FREDERIK-PHILIPS BOULEVARD SUITE 420 MONTREAL A8 H4M 2X6 CAN

www.milestonepharma.com Employees: 38 P: 514-336-0444

Sector:

Medical

Description:

Milestone Pharmaceuticals Inc. is a clinical-stage biopharmaceutical company. It is engaged in developing and commercializing the investigational new drug etripamil for the treatment of cardiovascular indications. The company's lead product candidate consists of MSP-2017, a nasal spray. Milestone Pharmaceuticals Inc. is based in Montr'al, Canada.

Key Statistics

Overview:

Market Capitalization, $K 229,703
Enterprise Value, $K 156,653
Shares Outstanding, K 119,637
Float, K 96,308
% Float 80.50%
Short Interest, K 10,326
Short Float 8.63%
Days to Cover 2.80
Short Volume Ratio 0.58
% of Insider Shareholders 19.50%
% of Institutional Shareholders 86.18%

Financials:

Annual Sales, $ 1,550 K
Annual Net Income, $ -63,060 K
Last Quarter Sales, $ 1,500 K
Last Quarter Net Income, $ -17,410 K
EBIT, $ -63,680 K
EBITDA, $ -63,570 K

Growth:

1-Year Return 60.00%
3-Year Return -56.36%
5-Year Return -65.41%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 55.88%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.16 on 03/20/26
Next Earnings Date 05/13/26 [BMO]
Earnings Per Share ttm -0.79
EPS Growth vs. Prev Qtr -33.33%
EPS Growth vs. Prev Year 15.79%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

MIST Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -656.73%
Return-on-Assets % -81.19%
Profit Margin % -4,068.39%
Debt/Equity 0.00
Price/Sales 146.26
Price/Cash Flow N/A
Price/Book 4.81
Book Value/Share 0.39
Interest Coverage -15.42
60-Month Beta 1.04
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.